Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-14

Clinical Trial Update: Effect of a Probiotic Supplement on Gut Microbiota and Glycemic Control in Patients With Type 1 Diabetes (PRODIAB) [NA]

View source ↗

Summary

A clinical trial update describes a study evaluating the effect of a probiotic supplement on gut microbiota and glycemic control in Type 1 diabetes, with recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic supplement (unspecified)

Snippet

Sponsor: Universidad Católica San Antonio de Murcia | Conditions: Diabete Type 1 | NA | Status: NOT_YET_RECRUITING